The Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by virtually all human infectious agents except HIV. DMID provides funding opportunities and a comprehensive set of resources for researchers that support basic research, preclinical development, and clinical evaluation.
DMID conducts and supports research on nearly 300 infectious agents and investigates the biological properties of these pathogens and the immune system’s responses to them. Findings from this research are vital to NIAID efforts to create vaccines, drugs, and diagnostic tools to better diagnose, prevent, and treat infectious diseases.
Latest News Releases
- Recent Advances in Addressing Tuberculosis Give Hope for Future
February 11, 2020
- Infectious Diseases Clinical Research Consortium Awards Announced
December 19, 2019
NIAID Now Blog
- Addressing Rare Diseases: Gene Therapy and Beyond
February 20, 2020
- NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein
February 19, 2020
- New Images of Novel Coronavirus SARS-CoV-2 Now Available
February 13, 2020
The Future of Infectious Disease Research
NIAID is working to refine its infectious disease clinical research networks to better implement clinical trial protocols for testing experimental vaccines, biologics, therapeutics, diagnostics and devices.
NIAID and NIH offer a number of funding opportunities, including grants and contracts to conduct basic research, preclinical development, or clinical evaluation.
Potential Funding Opportunities:
- Concepts: Potential Opportunities for DMID
Resources for Researchers
DMID supports a comprehensive set of resources for researchers. Their purpose is to facilitate the preclinical and clinical research needed to translate the ideas generated through basic research into safe and effective drugs, vaccines, and diagnostics to control and prevent infectious diseases.